METALINEAR
metaLinear focuses on the identification and validation of new drug targets for difficult to treat bacterial infections. metaLinear uses a proprietary proteome engineering platform technology to uncover, characterise and validate new targets for antibiotics. Using very large libraries of Randomised proteins (R-teins) expressed in target bacteria, metaLinear will screen for novel targets responsible for the desired phenotype. A key advantage of this approach is the ability to de-risk targets and hence provide multiple efficiency gains in the traditional target and drug discovery process.
METALINEAR
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Alderley Edge, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.metalinear.co.uk
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
255 K GBP
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Investors List
Catapult Ventures
Catapult Ventures investment in Seed Round - metaLinear
Alderley Park Ventures
Alderley Park Ventures investment in Seed Round - metaLinear
GM&C Life Sciences Fund
GM&C Life Sciences Fund investment in Seed Round - metaLinear
Official Site Inspections
http://www.metalinear.co.uk
- Host name: asset-uk-l5p-server1.assetict.com
- IP address: 198.244.202.235
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "metaLinear"
METALINEAR LIMITED overview - Find and update company …
People for METALINEAR LIMITED (10466246) More for METALINEAR LIMITED (10466246) Registered office address 110 Harlow Terrace Harlow Terrace, Harrogate, England, HG2 0PP …See details»
metaLinear - Crunchbase Company Profile & Funding
MetaLinear focuses on the identification and validation of new drug targets for difficult to treat bacterial infections. metaLinear uses a proprietary proteome engineering platform technology …See details»
metaLinear 2025 Company Profile: Valuation, Funding & Investors
MetaLinear General Information Description. Provider of new microbial drugs intended to treat bacterial infections. The company's drugs use a proprietary proteome engineering technology …See details»
metaLinear Company Profile - Office Locations, Competitors, …
MetaLinear is a biotech company producing drug targets designed to treat bacterial infections. The company's targets use a proteome engineering technology to uncover, characterize, and …See details»
metaLinear - Products, Competitors, Financials, Employees, …
MetaLinear is a start-up biotechnology company founded in 2017, focused on the identification and validation of new drug targets for difficult to treat bacterial infections. The new investment …See details»
MetaLinear - Company Profile - Tracxn
Feb 23, 2025 metaLinear is a biotechnology company that engineers bacterial proteome to identify potential drug target sites. The technologies the company uses are Protein-protein …See details»
METALINEAR LIMITED Company Profile - Dun & Bradstreet
Metalinear limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / harrogate …See details»
metaLinear - Crunchbase
Organization. metaLinear . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
MetaLinear Ltd - Company Profile and News - Bloomberg Markets
Company profile page for MetaLinear Ltd including stock price, company news, executives, board members, and contact informationSee details»
METALINEAR LIMITED people - Find and update company …
Nov 7, 2016 METALINEAR LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»
metaLinear - VentureRadar
MetaLinear is a biotechnology company focused on the identification and validation of new drug targets for difficult to treat bacterial infections. VentureRadar Research / Company Website …See details»
metaLinear - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 23, 2017: Seed Round - …See details»
METALINEAR LIMITED - Filing history (free information
Company Results (links open in a new window) Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link …See details»
METALINEAR LIMITED - LinkedIn
METALINEAR LIMITED Biotechnology Follow Report this company About us Industry Biotechnology Headquarters HARROGATE Locations 110 HARLOW TERRACE …See details»
metaLinear - Catapult Ventures
MetaLinear's founder has extensive scientific and business expertise in the commercialisation of protein engineering that underpins metaLinear's business. The development of new therapies …See details»
metaLinear - Contacts, Employees, Board Members, Advisors
MetaLinear focuses on the identification and validation of new drug targets for difficult to treat bacterial infections.See details»
metaLinear Ltd secures £255k seed investment for targeted …
Nov 28, 2017 metaLinear is a start-up biotechnology company founded in 2017, focused on the identification and validation of new drug targets for difficult to treat bacterial infections. The …See details»
Paul Ko Ferrigno, metalLinear Ltd - University of York
Oct 21, 2019 Speaker(s): Paul Ko Ferrigno, CEO, metaLinear Ltd A York graduate, Paul has worked on cell cycle control by protein phosphorylation (PhD with Phil Cohen and Carl …See details»
Global estimates of rotavirus vaccine efficacy and effectiveness: a ...
Our approach enhances the understanding of global variation in rotavirus vaccine performance and can be used to inform predictions of the potential impact of rotavirus vaccines for …See details»
Digital Screen Time and Myopia - JAMA Network
Feb 21, 2025 World Health Organization. The impact of myopia and high myopia. Report of the Joint World Health Organization–Brien Holden Vision Institute Global Scientific Meeting on …See details»